Kiyotsugu Iede

2PUBLICATIONS
0CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Sep 24, 2020
Predictive implications of decreased CA19-9 at 8 weeks during nab-paclitaxel plus gemcitabine for the induction of second-line chemotherapy for patients with advanced pancreatic cancer.

Kiyotsugu Iede, Terumasa Yamada, Ryo Kato

|Jul 17, 2020
Efficacy of S-1 in second-line chemotherapy after nab-paclitaxel plus gemcitabine for patients with advanced pancreatic cancer.

Kiyotsugu Iede, Terumasa Yamada, Ryo Kato

Pageof 1

Frequent Collaborators